Page last updated: 2024-10-29

iopromide and Uveal Neoplasms

iopromide has been researched along with Uveal Neoplasms in 1 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Uveal Neoplasms: Tumors or cancer of the UVEA.

Research Excerpts

ExcerptRelevanceReference
"Fifteen patients with either hepatocellular carcinoma (HCC, n = 8) or hypervascular liver metastases from uveal melanoma (n = 7) underwent arterial and portal venous C-arm CT of the liver using intraarterial contrast media administration directly before TACE."1.35Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. ( Borchert, M; Frericks, BB; Justiz, J; Martus, P; Meyer, BC; Voges, M; Wacker, FK; Wolf, KJ, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyer, BC1
Frericks, BB1
Voges, M1
Borchert, M1
Martus, P1
Justiz, J1
Wolf, KJ1
Wacker, FK1

Other Studies

1 other study available for iopromide and Uveal Neoplasms

ArticleYear
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT.
    AJR. American journal of roentgenology, 2008, Volume: 190, Issue:4

    Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Diagnosis, D

2008